Taysha Gene Therapies, Inc.
Taysha Gene Therapies, Inc. (TSHA) Number of Employees – History & Annual Headcount
Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.
SEC EDGAR · FMP · TSHA · as of Mar 19, 2026
Latest filing snapshot
Taysha Gene Therapies, Inc. (TSHA) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗
TSHA Employee Count
2020 – 2025 · Annual · SEC filingSource: SEC annual filings · Hover bar to view year data · Click to view original filing
Employees History
| Filing Date | Employees | Change (1Y) | Growth (1Y) | SEC filing link |
|---|---|---|---|---|
| 2026-03-19 | 99 | +26 | +35.62% | |
| 2025-02-26 | 73 | +21 | +40.38% | |
| 2024-03-19 | 52 | -13 | -20.00% | |
| 2023-03-28 | 65 | -113 | -63.48% | |
| 2022-03-31 | 178 | +140 | +368.42% | |
| 2021-03-03 | 38 | — | — |
▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.
Related Companies — Employee Count
Biotechnology
About TSHA employees
TSHA Employees · Headcount
Taysha Gene Therapies, Inc. (TSHA) employee data is sourced from the annual SEC 10-K filing. As of 2025, Taysha Gene Therapies, Inc. had 99 full-time employees globally. Full-time employees only. Global consolidated headcount.
Taysha Gene Therapies, Inc. employs 99 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $98,717, reflecting the company's operational efficiency.
Taysha Gene Therapies, Inc.'s workforce increased by 26 (35.62%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.
Taysha Gene Therapies, Inc.'s revenue per employee of $98,717 positions it among the notable performers in the Biotechnology sector for operational efficiency.
Frequently Asked Questions
TSHA Employees · 5 questionsAs of the latest SEC 10-K filing (2025), Taysha Gene Therapies, Inc. had 99 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.
▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-19